| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.6M | +223.4% |
| R&D Expense | $151.4M | -5.0% |
| SG&A Expense | $70.4M | +87.2% |
| Operating Income | -$176.3M | +3.6% |
| Interest Expense | $287K | — |
| Pre-tax Income | -$241.6M | -36.6% |
| Income Tax | -$1K | -103.7% |
| Net Income | -$241.6M | -36.5% |
| EPS (Basic) | -$2.56 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $771.7M | +126.7% |
| Short-term Investments | $62.4M | — |
| Current Assets | $863.4M | +149.0% |
| Total Assets | $864.6M | +149.1% |
| Current Liabilities | $106.9M | +114.3% |
| Total Liabilities | $107.1M | +82.5% |
| Stockholders' Equity | $757.5M | +162.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$158.6M | -12.3% |
| Investing Cash Flow | -$62.8M | — |
| Financing Cash Flow | $659.5M | +7300.2% |
| -19.1% |
| EPS (Diluted) | -$2.56 | -19.1% |